Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2020-06-25 Major Shareholding Noti…
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly starts with 'RNS Number : 1278R' and contains the header 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)'. It details changes in voting rights percentages (e.g., 3.10%, 1.63%) held by a shareholder (SPREADEX LTD) in Genedrive PLC, referencing specific regulatory directives (Directive 2004/109/EC). This structure perfectly matches the definition of a Major Shareholding Notification. The presence of 'RNS Number' and the closing statement referencing RNS and the FCA confirms it is a regulatory announcement, but the specific content points directly to 'Major Shareholding Notification' (MRQ) over the general 'RNS' fallback.
2020-06-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 6923Q' and contains the header 'National Storage Mechanism | Additional information'. The content is a 'TR-1: Standard form for notification of major holdings', which details changes in voting rights percentages (crossing thresholds from 10.41% to 8.98%). This type of mandatory disclosure regarding significant changes in share ownership is classified as a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-06-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly starts with 'RNS Number : 6621Q' and contains the header 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS stands for Regulatory News Service, which is the primary channel for listed companies in the UK to disseminate regulatory information. The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in significant share ownership (crossing a threshold from 7.815% to 6.361%). This type of filing directly corresponds to the definition of Major Shareholding Notification (MRQ). However, since the document is a formal regulatory disclosure distributed via the RNS system, and the MRQ definition is very specific, I must check if RNS (Regulatory Filings) is a better fit or if MRQ is preferred. Given the specific nature of the content (major holding change), MRQ is the most precise classification. The document is not a short announcement linking to a report, but the report itself.
2020-06-22 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1371 characters) and is explicitly labeled with an 'RNS Number'. The content describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, which is a specific, non-standard regulatory event notification. Since it is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), and it is a direct notification from the RNS service, it best fits the general 'Regulatory Filings' fallback category (RNS).
2020-06-18 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1354 characters) and begins with an 'RNS Number' (3851Q), indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading mechanisms, not a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories (AGM-R, 10-K, ER, DIV, etc.), the most appropriate fallback category is 'Regulatory Filings' (RNS).
2020-06-18 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1371 characters) and is explicitly labeled with an 'RNS Number : 2872Q'. The content describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, which is a specific, non-standard regulatory event notification. Since it is a brief, specific announcement provided by RNS (the news service of the London Stock Exchange) and does not fit into the categories for financial reports (10-K, IR, ER) or specific corporate actions (DIV, SHA, DIRS), the most appropriate classification is the general regulatory announcement fallback category.
2020-06-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.